Published in Physician Law Weekly, May 9th, 2007
The pilot study of the Impella 2.5 enrolled patients undergoing high-risk angioplasty procedures at the trial sites of William Beaumont Hospital, Brigham and Women's Hospital, Massachusetts General Hospital, Texas Heart Institute, Cedars-Sinai Medical Center, Scripps Clinic and the Academic Medical Center in Amsterdam. Angioplasty, performed in the catheterization lab, is the insertion of a...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Physician Law Weekly